Related references
Note: Only part of the references are listed.GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE(-/-) Mice
Naim Panjwani et al.
ENDOCRINOLOGY (2013)
The Glucagon-Like Peptide-1 Receptor-or Not?
Charles Pyke et al.
ENDOCRINOLOGY (2013)
SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion
Sindhu Rajan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Glucose exposure pattern determines glucagon-like peptide 1 receptor expression and signaling through endoplasmic reticulum stress in rat insulinoma cells
Ye-Hwang Cheong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Control of Pancreatic β Cell Regeneration by Glucose Metabolism
Shay Porat et al.
CELL METABOLISM (2011)
Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
Jun Shirakawa et al.
DIABETES (2011)
Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice
A. Maida et al.
DIABETOLOGIA (2011)
New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser
Y. M. Cho et al.
DIABETOLOGIA (2011)
AMP-activated protein kinase regulates glucagon secretion from mouse pancreatic alpha cells
I. Leclerc et al.
DIABETOLOGIA (2011)
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
M. A. Nauck et al.
DIABETOLOGIA (2011)
Protective Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor against Increased β Cell Apoptosis Induced by Dietary Sucrose and Linoleic Acid in Mice with Diabetes
Jun Shirakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Management of type 2 diabetes: new and future developments in treatment
Abd A. Tahrani et al.
LANCET (2011)
GLP-1 Inhibits and Adrenaline Stimulates Glucagon Release by Differential Modulation of N- and L-Type Ca2+ Channel-Dependent Exocytosis
Yang Z. De Marinis et al.
CELL METABOLISM (2010)
Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1
E. M. Migoya et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Ablation of AMP-activated protein kinase α1 and α2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo
G. Sun et al.
DIABETOLOGIA (2010)
The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 β cells
Luisa Garcia-Haro et al.
FASEB JOURNAL (2010)
Glycaemic control in type 2 diabetes: Targets and new therapies
Abd A. Tahrani et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes
J. Cuthbertson et al.
DIABETIC MEDICINE (2009)
Glucose, Metformin, and AICAR Regulate the Expression of G Protein-coupled Receptor Members in INS-1 β Cell
Q. R. Pan et al.
HORMONE AND METABOLIC RESEARCH (2009)
The AMP-regulated kinase family: Enigmatic targets for diabetes therapy
Guy A. Rutter et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Assessing the potential of glucokinase activators in diabetes therapy
Franz M. Matschinsky
NATURE REVIEWS DRUG DISCOVERY (2009)
Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice
Gitte Jositsch et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific
Brian C. Jensen et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Should we be cautious on the use of commercially available antibodies to dopamine receptors?
Serena Bodei et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Lack of specificity of antibodies directed against human beta-adrenergic receptors
Nazha Hamdani et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice
Xiaoying Lu et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors
Wisuit Pradidarcheep et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Transgenic expression of antioxidant protein thioredoxin in pancreatic beta cells prevents progression of type 2 diabetes mellitus
Mayu Yamamoto et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic β-cells through restoration of mitochondrial electron transfer
S. A. Hinke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Disruption of leptin receptor expression in the pancreas directly affects β cell growth and function in mice
Tomoaki Morioka et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The role of AMPK and mTOR in nutrient sensing in pancreatic β-cells
Catherine E. Gleason et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes
D. R. Laybutt et al.
DIABETOLOGIA (2007)
Downregulation of GLP-1 and GIP receptor expression by hyperglycemia - Possible contribution to impaired incretin effects in diabetes
Gang Xu et al.
DIABETES (2007)
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1
Brian D. Green et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
AMP-activated protein kinase signaling in metabolic regulation
Yun Chau Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
Pioglitazone improves insulin secretory capacity and prevents the loss of β-cell mass in obese diabetic db/db mice:: Possible protection of β cells from oxidative stress
H Ishida et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
JJ Holst et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Unspecific labeling of pancreatic islets by antisera against fibroblast growth factors and their receptors
DS Dichmann et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models
B Viollet et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
AE Butler et al.
DIABETES (2003)
Enhanced secretion of glucagon-like peptide 1 by biguanide compounds
N Yasuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats
FC Lynn et al.
DIABETES (2001)
Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects
E Mannucci et al.
DIABETES CARE (2001)
Role of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expression
GD Xavier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
